In contrast, in the HFD-fed MUP-uPA HCC mouse model, removing CD8+ T cells accelerated HCC, suggesting that CD8+ T cells have anti-HCC function in NASH. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatohepatitis.